المؤلفون: Alexey eGoltsov, Simon eLangdon, Gregory eGoltsov, David eHarrison, James eBown

المصدر: Frontiers in Oncology, Vol 4 (2014)

مصطلحات موضوعية: Pathway Engineering, signalling networks, Pertuzumab, anticancer combination therapy, cancer drug resistance, PI3K/PTEN/AKT, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00013/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/5110a324f1424a55bddfd0ea214f9461Test

المؤلفون: David J. Harrison, Simon P. Langdon, James L. Bown, Alexey Goltsov, Gregory Goltsov

المساهمون: University of St Andrews. School of Medicine

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 4 (2014)
Goltsov, A, Langdon, S P, Goltsov, G, Harrison, D J & Bown, J 2014, ' Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinations ', Frontiers in Oncology, vol. 4, pp. 13 . https://doi.org/10.3389/fonc.2014.00013Test

مصطلحات موضوعية: Drug, Anti-cancer combination therapy, Cancer Research, Combination therapy, cancer drug resistance, media_common.quotation_subject, In silico, signaling networks, Drug action, Computational biology, Drug resistance, Pharmacology, anticancer combination therapy, lcsh:RC254-282, anti-cancer combination therapy, RC0254, SDG 3 - Good Health and Well-being, ErbB, pertuzumab, Signaling networks, Pathway engineering, medicine, signalling networks, PI3K/AKT/mTOR pathway, media_common, Original Research, RC0254 Neoplasms. Tumors. Oncology (including Cancer), business.industry, Pertuzmab, Cancer drug resistance, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Oncology, Pertuzumab, pathway engineering, PI3K/PTEN/AKT, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590b730a4ddbbf3bb57f4e9fcd057fc7Test
http://europepmc.org/articles/PMC3914444Test